Non-HLA Genetic Factors and Their Influence on Heart Transplant Outcomes: A Systematic Review

by Jessica van Setten, PhD, Evangeline G. Warmerdam, MD, Olivier Q. Groot, BSc, Nicolaas de Jonge, MD, Brendan Keating, PhD, Folkert W. Asselbergs, MD, PhD
Published 2019-02-01

Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics

by Janine A.M. Kamphuis, MD, Marijke Linschoten, MD, Maarten J. Cramer, MD, PhD, Eelke H. Gort, MD, PhD, Anna van Rhenen, MD, PhD, Folkert W. Asselbergs, MD, PhD, Pieter A. Doevendans, MD, PhD, Arco J. Teske, MD, PhD
Published 2019-12-01

Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular Disease

by Cilie C. van ’t Klooster, MD, Paul M. Ridker, MD, PhD, Nancy R. Cook, PhD, Joachim G.J.V. Aerts, MD, PhD, Jan Westerink, MD, PhD, Folkert W. Asselbergs, MD, PhD, Yolanda van der Graaf, MD, PhD, Frank L.J. Visseren, MD, PhD, F.W. Asselbergs, H.M. Nathoe, G.J. de Borst, M.L. Bots, M.I. Geerlings, M.H. Emmelot, P.A. de Jong, T. Leiner, A.T. Lely, N.P. van der Kaaij, L.J. Kappelle, Y. Ruigrok, M.C. Verhaar, J. Westerink
Published 2020-09-01